Sutro Biopharma Inc (STRO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access STRO Annual Balance Sheets →
A period-by-period view of the balance sheet from Sutro Biopharma Inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent54.34
Marketable Securities, Current SH110.01
Cash & Short-term Investments164.00
Accounts receivable5.80
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.50
Total Current Assets175.65
Equipment/Property/Plant Net8.36
Other Assets, Noncurrent10.46
Restricted Cash Noncurrent0.86
Total Assets194.46
Liabilities
Accounts Payable, Current AC3.36
Accrued Liabilities, Current AC6.19
Other Liabilities, Current43.36
Total Current Liabilities52.90
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent0.28
Other liabilities, Noncurrent244.61
Accrued Expenses And Other Current Liabilities42.97
Operating Lease Liability Current7.60
Contract With Customer Liability Noncurrent1.23
Deferred Royalty Obligation Related To Sale Of Future Royalties Noncurrent229.11
Total Liabilities297.78
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock951.70
Retained Earnings / Accumulated Deficit-1,054.97
Accumulated Other Comprehensive Income-0.06
Other Equity-0.06
Common Stockholder's Equity-103.32
Total Stockholder's Equity-103.32
Liabilities & Stockholder's Equity194.46
4 historic quarters locked

Sign in to unlock the full Sutro Biopharma Inc balance sheet history.

About Sutro Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-345748

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.